Gelterkinden, Switzerland

Andreas Hafner

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 3.9

ph-index = 12

Forward Citations = 376(Granted Patents)


Location History:

  • Frenkendorf, CH (1991 - 1994)
  • Laupen, CH (1994 - 2001)
  • Gelterkinden, SE (2004)
  • Gelterkinden BL, CH (2014)
  • Gelterkinder, DE (2017)
  • Gelterkinden, CH (2000 - 2018)

Company Filing History:


Years Active: 1991-2018

Loading Chart...
Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents

Title: Andreas Hafner: Innovator in Pharmaceutical Patents

Introduction: Andreas Hafner, based in Gelterkinden, Switzerland, is a prominent inventor with an impressive portfolio of 45 patents. His contributions to the pharmaceutical field have significantly advanced the development of drug formulations and delivery systems.

Latest Patents: Hafner's latest innovations include the patent for "Multi-component crystals of vismodegib and selected co-crystal formers or solvents." This invention primarily focuses on creating multi-component crystals that involve a specific compound and a second compound selected from co-crystal formers and solvents. The benefits of this invention extend to pharmaceutical compositions that utilize these multi-component crystals for disease treatment. Another significant patent introduced by Hafner is for the "Solid form of abiraterone acetate," which explores combinations of Abiraterone acetate with various acidic substances. This innovation shows enhanced properties such as improved aqueous solubility and dissolution kinetics, particularly when presented in the form of cocrystals or in combination with suitable acids.

Career Highlights: Hafner's professional journey includes notable stints at reputed organizations, such as Ciba Specialty Chemicals Corporation and BASF SE Corporation. His work within these companies has positioned him at the forefront of pharmaceutical innovation, contributing to various projects that emphasize the importance of solid forms of compounds in drug formulations.

Collaborations: Throughout his career, Hafner has collaborated with esteemed coworkers, including Paul Adriaan Van Der Schaaf and Andreas Muhlebach. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of expertise in the field of pharmaceuticals.

Conclusion: Andreas Hafner’s contributions to the pharmaceutical industry through his numerous patents highlight his role as an influential inventor. His innovations not only enhance the efficacy of existing drug compositions but also pave the way for new therapeutic applications. As he continues to explore new frontiers in pharmaceutical science, Hafner remains a key figure in the ongoing development of innovative drug solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…